Global Biopreservation Market is expected to touch US$ 5.44 billion in 2024 and to reach US$ 24.51 billion by 2033, with a CAGR of 18.20% during 2025-2033. The main driving factors behind this growth include the rising demand for personalized medicine, R&D investments, and growing awareness about rare diseases.
In the medical application, biopreservation provides for preservation of viable and functional stem cells, blood products, and organs for transplantation when needed. In addition, it serves as a crucial additional support in the pharmaceutical industry in the development of biologics and personalized medicine. It prevents cell damage through freezing or chemical degradation, allowing such valuable biological materials to be preserved over long periods for clinical and research use.
2. Media
3. Laboratory Information Management System (LIMS)
2. Biobanking
3. Drug Discovery
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 Australia
3.5 South Korea
3.6 Thailand
3.7 Malaysia
3.8 Indonesia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 South Africa
5.2 Saudi Arabia
5.3 UAE
2. Cryport, Inc.
3. Eppendorf AG
4. BioLife Solutions Inc
5. Azenta Inc
6. Merck KGaA
7. Qiagen NV
8. Chart Industries, Inc.
Biopreservation Industry Outlooks
Biopreservation is a method of using or handling the natural or controlled environment of microbiota with other biologically active agents in such a way that bio-material like cells, tissues, and organs do not deteriorate. Biopreservation is an extremely important process because it keeps biologically based samples viable, functional, and safe for long periods of time. In the health and life sciences sector, there are various applications of biopreservation practices, including the preservation and transport of human cells, tissues, vaccines, and much more.In the medical application, biopreservation provides for preservation of viable and functional stem cells, blood products, and organs for transplantation when needed. In addition, it serves as a crucial additional support in the pharmaceutical industry in the development of biologics and personalized medicine. It prevents cell damage through freezing or chemical degradation, allowing such valuable biological materials to be preserved over long periods for clinical and research use.
Driving Forces of the Biopreservation Market
Increasing Demand for Personalized Medicine
The growing trend of treatment tailored to a patient's unique genetic makeup is undoubtedly one of the significant driving forces of the biopreservation market. Thus, demand exists for the preservation of samples such as stem cells and DNA and also tissue samples for their application in diagnostic and therapeutic areas. Biopreservation ensures such samples are preserved in viable form for research and clinical use. This translates to more effective, individualized treatments. As patients turn to personalized therapies in greater numbers, there would be greater demand for biopreservation technologies that are adequate, reliable, and strong enough in preserving the integrity of such samples.Biotechnology Advancements and Research
There has been a growing emphasis on cell-based therapies and regenerative medicine, which has driven a heightened call for biopreservation. Advances in biotechnology have enhanced the demand for biopreservation. This would involve long-term storage and transport of sensitive biological materials in research activities on stem cell therapies, gene therapies, and vaccine development. For the cells and tissues to have stability and functionality, these technologies in biopreservation include cryopreservation as well as preservation media. The growth in the market of biopreservation would be able to sustain the pace of innovation in the sector of biotechnology for innovative research and medical applications.Knowledge on Rare Diseases is Increasing
The increasing awareness of rare and genetic diseases triggers the growth of the biopreservation market. Increasing research activities over rare conditions increase emphasis on preservations of biological samples for diagnostic and therapeutic purposes. By maintaining the viability of these samples for a longer period, biopreservation provides adequate support to the research and development of treatments in such diseases. As rare diseases become increasingly better understood worldwide, there would be increased demand for effective biological material storage and preservation since biopreservation solutions in medical research, clinical diagnostics, and drug development would be required.Canada Biopreservation Industry
The growth of the Canadian biopreservation market is fueled by an increasing demand for personalized medicine and the trend of advancements in biotechnology. As the country continues to invest in leading-edge research and development, there is thus an emergent imperative to preserve samples of biological matter such as stem cells, tissues, and DNA for both research and medical use. Secondly, the Canadian healthcare sector is keen on improving the diagnosis and treatment of rare diseases, further increasing the need for biopreservation technologies. The country's strong biopharmaceuticals and biotechnology sectors, combined with regulations, would remain positive drivers for the biopreservation market in Canada, going forward. July 2024 Formycon AG, Polpharma Biologics Group BV, Bioeq AG, Teva Canada Ltd. announce that Health Canada has granted Notice of Compliance to Ranopto for the treatment of serious retinal diseases for several conditions in the country.Biopreservation Market in France
Growth in the French biopreservation market is very strong because of the robust infrastructural health care system, though increasing investments in biotechnology are further adding fuel to this market. The emerging theme of personalized medicine, stem cell therapies, and regenerative medicine require technologies for biopreservation to store and preserve biological samples such as tissues, cells, and DNA. These include research in life sciences by the French government, advances in cryopreservation, and other biopreservation methods that are fueling the growth of the market. With a focus on rare diseases research and innovation in the healthcare sector, France's biopreservation industry will continue to grow at an exponential rate in the coming years.India Biopreservation Industry
The Indian biopreservation market is growing. It is primarily driven by the increasing demand for personalized medication, higher utilization of biotechnology, and modern health techniques. Gains from India in terms of focus toward regenerative medicine, stem cell research, and gene therapies are likely to drive the development of effective biopreservation methods-the storage and preservation of biological samples such as cells, tissues, and DNA. Meanwhile, increased awareness of rare diseases, government support to strengthen healthcare, and biotechnology sectors is further strengthening market growth. At the same time, with higher investments in life science research and healthcare infrastructure, India's biopreservation industry will quite likely remain on an expansion spree. July 2022- Cellutions BioStorage, a research-to-launch cryopreservation bank was launched in Chennai, India. Cellutions BioStorage is a full-service biomaterial storage and logistics company that partners with biopharmaceutical companies seeking to outsource supply chain management for every stage in a product's lifecycle. The newly constructed facility is of first-class infrastructure and encompasses 25,000 square feet.Global Biopreservation Company Analysis
The global major players in the biopreservation companies are Thermo Fisher Scientific Inc., Cryport, Inc., Eppendorf AG, BioLife Solutions Inc., Azenta Inc., Merck KGaA, Qiagen NV, and Chart Industries, Inc.Product- Market breakup in 3 viewpoints:
1. Equipment2. Media
3. Laboratory Information Management System (LIMS)
Application- Market breakup in 3 viewpoints:
1. Regenerative Medicine2. Biobanking
3. Drug Discovery
Countries- Market breakup in 25 viewpoints:
1. North America1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 Australia
3.5 South Korea
3.6 Thailand
3.7 Malaysia
3.8 Indonesia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 South Africa
5.2 Saudi Arabia
5.3 UAE
All the key players have been covered from 4 Viewpoints:
- Business Overview
- Key Persons
- Recent Development & Strategies
- Financial Insights
Key Players Analysis:
1. Thermo Fisher Scientific Inc.2. Cryport, Inc.
3. Eppendorf AG
4. BioLife Solutions Inc
5. Azenta Inc
6. Merck KGaA
7. Qiagen NV
8. Chart Industries, Inc.
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. Global Biopreservation Market
4. Market Dynamics
6. Market Share Analysis
7. Product
8. Application
9. Countries
10. Porter’s Five Forces Analysis
11. SWOT Analysis
12. Key Players Analysis
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Cryport, Inc.
- Eppendorf AG
- BioLife Solutions Inc
- Azenta Inc
- Merck KGaA
- Qiagen NV
- Chart Industries, Inc.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | November 2024 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 5.44 Billion |
| Forecasted Market Value ( USD | $ 24.51 Billion |
| Compound Annual Growth Rate | 18.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
![Biopreservation Market by Product (Media [Cryopreservation, Hypothermic]), Equipment (Freezers, Refrigerators, Incubators, Centrifuge, Accessories), Biospecimen (Tissues, Organs, Stem Cells), Application (Research, Therapeutic) - Forecast to 2029 - Product Image](http://www.researchandmarkets.com/product_images/11622/11622592_60px_jpg/biopreservation_market.jpg)
